Home> Products> glucose reabsorption

{ "products": [ { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad7442bf24c5a4bbccf4b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets", "description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.", "price": 230.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2504, "imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:36:27.325Z", "updatedon": "2026-10-20T10:36:27.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 25", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a1ec0fb574466f5ec21abe8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "description": "Generate unique content Seo geo friendly At least 1500 words humanizes and long and detailed articles on composition “ gliclazide and dapagliflozin combination\n\n” using brand name “ GLICLAGLAZE DAPA 60-10” use composition in heading “gliclazide and dapagliflozin combination ” and also use brand name Steris healthcare……. H1 How works……H2 Why its important …….H2 Key Benefits of ……….H3 What are the benefits …….H2 Side effects………H3 Serious Side Effects Of ……….H3 Available Substitute For ……….H2 Dosage Guidelines For …..H2 Precautions & Warnings: …..H2 with using and also Mechanism to action also with composition“gliclazide and dapagliflozin combination” Target Buyer intent INDICATIONS, EFFICACY AND CLINICAL EVIDENCE keywords”” : Conclusion: keep conclusion and Frequently Asked Questions 1 Is it safe to take gliclazide and dapagliflozin together? 2 What are the benefits of taking gliclazide and dapagliflozin concurrently? 3 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin? 4 Where can I find a doctor specializing in diabetes management who prescribes this combination? 5 Where can I buy gliclazide and dapagliflozin in one prescription? 6 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nFor Further More Information: \n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +918824175417, +919982524671\n\nBuy Now\n\nBelow is SEO-friendly, GEO-optimized, buyer-intent content for your product page targeting “gliclazide and dapagliflozin combination” and branded as GLICLAGLAZE DAPA 60-10 from Steris Healthcare.\n\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\n\nDiabetes mellitus is one of the most common chronic metabolic disorders affecting millions of people worldwide. Effective blood sugar management requires a comprehensive treatment approach that helps control glucose levels, reduce complications, and improve overall quality of life. The gliclazide and dapagliflozin combination has emerged as an effective therapeutic option for patients with Type 2 Diabetes Mellitus (T2DM) who require better glycemic control.\n\nGLICLAGLAZE DAPA 60-10, developed by Steris Healthcare, combines the proven efficacy of Gliclazide 60 mg Sustained Release and Dapagliflozin 10 mg to provide dual-action blood glucose control. This innovative combination works through complementary mechanisms to help diabetic patients achieve target blood sugar levels effectively.\n\nThis detailed guide covers the mechanism of action, indications, benefits, dosage guidelines, precautions, efficacy, clinical evidence, side effects, and frequently asked questions regarding the gliclazide and dapagliflozin combination.\n\nHow Gliclazide and Dapagliflozin Combination Works\n\nThe gliclazide and dapagliflozin combination utilizes two distinct yet complementary mechanisms to lower blood glucose levels.\n\nGliclazide Mechanism of Action\n\nGliclazide belongs to the sulfonylurea class of antidiabetic medications. It stimulates the pancreatic beta cells to release insulin, helping the body reduce elevated blood sugar levels.\n\nKey actions include:\n\nIncreases insulin secretion from the pancreas\nImproves glucose utilization\nReduces fasting blood glucose\nEnhances post-meal glucose control\nHelps maintain long-term glycemic stability\nDapagliflozin Mechanism of Action\n\nDapagliflozin belongs to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class.\n\nIt works by:\n\nBlocking glucose reabsorption in the kidneys\nIncreasing glucose excretion through urine\nReducing blood sugar independently of insulin\nPromoting mild weight reduction\nSupporting cardiovascular and renal protection\nCombined Mechanism of Action\n\nWhen combined, Gliclazide and Dapagliflozin provide:\n\nIncreased insulin secretion\nReduced renal glucose reabsorption\nBetter fasting and postprandial glucose control\nLower HbA1c levels\nImproved metabolic outcomes\n\nThis dual-action approach makes GLICLAGLAZE DAPA 60-10 a highly effective treatment for Type 2 Diabetes Mellitus.\n\nWhy Its Important\n\nManaging diabetes effectively is essential to prevent serious complications such as:\n\nHeart disease\nStroke\nKidney damage\nNerve damage\nVision loss\nDiabetic foot complications\n\nThe gliclazide and dapagliflozin combination is important because it addresses multiple aspects of blood sugar regulation while offering additional metabolic and cardiovascular benefits.\n\nFor patients whose diabetes remains uncontrolled with single-drug therapy, combination treatment provides enhanced glucose management and improved treatment outcomes.\n\nKey Benefits of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 offers several significant benefits for diabetic patients.\n\nBetter Blood Sugar Control\n\nThe combination effectively lowers fasting and post-meal blood glucose levels.\n\nSignificant HbA1c Reduction\n\nClinical studies demonstrate meaningful reductions in HbA1c levels, helping patients achieve glycemic targets.\n\nWeight Management Support\n\nDapagliflozin promotes urinary glucose excretion, which may contribute to modest weight loss.\n\nReduced Risk of Diabetes Complications\n\nConsistent glycemic control lowers the risk of long-term diabetic complications.\n\nCardiovascular Benefits\n\nDapagliflozin has demonstrated cardiovascular protective effects in high-risk diabetic patients.\n\nRenal Protection\n\nThe medication supports kidney health and may slow progression of diabetic kidney disease.\n\nConvenient Once-Daily Dosing\n\nThe formulation enhances patient compliance through simple administration.\n\nWhat Are the Benefits of Gliclazide and Dapagliflozin Combination?\n\nPatients taking GLICLAGLAZE DAPA 60-10 may experience:\n\nImproved glycemic control\nBetter insulin utilization\nLower HbA1c values\nEnhanced metabolic function\nReduced fasting blood sugar\nBetter postprandial glucose management\nWeight management support\nImproved cardiovascular outcomes\nRenal protective effects\nIncreased treatment adherence\nIndications of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 is indicated for:\n\nType 2 Diabetes Mellitus\n\nUsed in adults when diet, exercise, and monotherapy do not adequately control blood glucose.\n\nInadequate Glycemic Control\n\nRecommended for patients requiring intensified diabetes treatment.\n\nLong-Term Diabetes Management\n\nSupports sustained blood glucose control and prevention of complications.\n\nPatients with Cardiovascular Risk Factors\n\nMay provide additional cardiovascular benefits alongside glycemic management.\n\nEfficacy and Clinical Evidence\n\nSeveral clinical studies support the effectiveness of combining sulfonylureas such as Gliclazide with SGLT2 inhibitors like Dapagliflozin.\n\nHbA1c Reduction\n\nClinical trials demonstrate:\n\nSignificant reductions in HbA1c levels\nImproved fasting plasma glucose\nEnhanced postprandial glucose control\nWeight Reduction\n\nDapagliflozin contributes to calorie loss through urinary glucose excretion, leading to modest weight reduction.\n\nCardiovascular Outcomes\n\nResearch indicates that SGLT2 inhibitors may reduce hospitalization for heart failure and improve cardiovascular outcomes.\n\nRenal Outcomes\n\nStudies have shown benefits in slowing progression of diabetic kidney disease and improving renal function markers.\n\nThese findings make the gliclazide and dapagliflozin combination a valuable therapeutic option for comprehensive diabetes management.\n\nSide Effects of Gliclazide and Dapagliflozin Combination\n\nLike all medications, GLICLAGLAZE DAPA 60-10 may cause side effects.\n\nCommon side effects include:\n\nHeadache\nDizziness\nFrequent urination\nIncreased thirst\nNausea\nFatigue\nMild urinary tract infections\nGenital fungal infections\nLow blood sugar (hypoglycemia)\n\nMost side effects are mild and manageable.\n\nSerious Side Effects Of Gliclazide and Dapagliflozin Combination\n\nAlthough uncommon, serious side effects may include:\n\nSevere hypoglycemia\nDiabetic ketoacidosis\nSevere dehydration\nAcute kidney injury\nSerious urinary tract infections\nAllergic reactions\nSevere skin reactions\n\nSeek immediate medical attention if serious symptoms occur.\n\nAvailable Substitute For Gliclazide and Dapagliflozin Combination\n\nAlternative antidiabetic combinations may include:\n\nMetformin + Dapagliflozin\nSitagliptin + Dapagliflozin\nGliclazide + Metformin\nGlimepiride + Dapagliflozin\nEmpagliflozin-based combinations\n\nThe choice of therapy should always be determined by a healthcare professional based on individual patient needs.\n\nDosage Guidelines For Gliclazide and Dapagliflozin Combination\nRecommended Dose\n\nTake GLICLAGLAZE DAPA 60-10 exactly as prescribed by your physician.\n\nAdministration Instructions\nUsually taken once daily\nSwallow the tablet whole\nDo not crush or chew sustained-release tablets\nTake with or after food if advised\nMaintain adequate hydration\nMissed Dose\n\nIf a dose is missed:\n\nTake it as soon as remembered\nSkip if close to the next scheduled dose\nDo not double the dose\nOverdose\n\nSeek immediate medical attention in case of overdose.\n\nPrecautions & Warnings: Gliclazide and Dapagliflozin Combination\nMonitor Blood Sugar Regularly\n\nFrequent blood glucose monitoring helps optimize treatment outcomes.\n\nRisk of Hypoglycemia\n\nPatients should recognize symptoms such as:\n\nSweating\nTremors\nHunger\nConfusion\nDizziness\nMaintain Hydration\n\nDapagliflozin increases urinary glucose excretion and may increase fluid loss.\n\nKidney Function Monitoring\n\nRegular renal function assessments are recommended.\n\nLiver Function Monitoring\n\nPeriodic liver function evaluation may be necessary.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare professional before use during pregnancy or lactation.\n\nAlcohol Consumption\n\nAlcohol may increase the risk of hypoglycemia and should be used cautiously.\n\nElderly Patients\n\nAdditional monitoring may be required due to increased sensitivity to treatment effects.\n\nWhy Choose GLICLAGLAZE DAPA 60-10 from Steris Healthcare?\n\nSteris Healthcare is committed to providing high-quality pharmaceutical products that support better patient outcomes.\n\nBenefits include:\n\nHigh manufacturing standards\nReliable quality assurance\nEffective diabetes management solution\nAdvanced combination therapy\nImproved patient compliance\nTrusted healthcare support\n\nGLICLAGLAZE DAPA 60-10 reflects Steris Healthcare’s dedication to innovation and excellence in diabetes care.\n\nConclusion\n\nThe gliclazide and dapagliflozin combination found in GLICLAGLAZE DAPA 60-10 offers a comprehensive and effective approach to Type 2 Diabetes Mellitus management. By combining the insulin-stimulating effects of Gliclazide with the glucose-excreting action of Dapagliflozin, this therapy provides superior blood sugar control, improved HbA1c reduction, cardiovascular support, renal protection, and enhanced patient convenience.\n\nFor patients seeking better glycemic control and long-term diabetes management, GLICLAGLAZE DAPA 60-10 from Steris Healthcare represents a scientifically supported and clinically effective treatment option.\n\nBuy Now\n\nFor product inquiries, bulk orders, franchise opportunities, and distribution partnerships:\n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +91 8824175417, +91 9982524671\n\nBuy Now: Contact Steris Healthcare for product availability and ordering information.\n\nFrequently Asked Questions (FAQs)\n1. Is it safe to take gliclazide and dapagliflozin together?\n\nYes. Under medical supervision, the combination is considered safe and effective for managing Type 2 Diabetes Mellitus.\n\n2. What are the benefits of taking gliclazide and dapagliflozin concurrently?\n\nThe combination offers improved blood sugar control, HbA1c reduction, weight management support, cardiovascular benefits, and renal protection.\n\n3. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nMany retail pharmacies, hospital pharmacies, and authorized pharmaceutical distributors stock gliclazide and dapagliflozin combination products. Availability may vary by location.\n\n4. Where can I find a doctor specializing in diabetes management who prescribes this combination?\n\nEndocrinologists, diabetologists, and experienced physicians commonly prescribe this combination for Type 2 Diabetes management.\n\n5. Where can I buy gliclazide and dapagliflozin in one prescription?\n\nYou can obtain the medication through a valid prescription from a registered healthcare professional and purchase it from authorized pharmacies.\n\n6. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nLicensed pharmacies, diabetes specialty centers, and authorized pharmaceutical distributors often provide combination antidiabetic therapies, including GLICLAGLAZE DAPA 60-10.\n\ncreate 3d image without changing product image\nEdit\ncreate 3d image without changing product image please regenerate again\nEdit\nThis is my product page H1 Title “ Benfotiamine Mecobalamin,Pyridoxine Hydrochloride Folic Acid,Inositol & Alpha Lipoic Acid Capsules” generate complete as a buyer intent reading content on this targted keyword. content must between 1000- 1200 words \nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules – Complete Guide for Nerve Health and Diabetic Neuropathy Support\n\nMaintaining healthy nerves is essential for overall well-being, especially for individuals living with diabetes, nutritional deficiencies, metabolic disorders, and nerve-related complications. Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are scientifically formulated to provide comprehensive nutritional support for nerve health, improve nerve function, and help manage symptoms associated with diabetic neuropathy and peripheral nerve disorders.\n\nThis advanced combination contains essential neurotropic vitamins and antioxidants that work together to nourish damaged nerves, improve nerve conduction, reduce oxidative stress, and support overall neurological health. These capsules are widely prescribed by healthcare professionals for patients experiencing tingling, numbness, burning sensations, nerve pain, and vitamin B deficiencies.\n\nWhether you are searching for an effective solution for diabetic neuropathy or looking to support long-term nerve health, Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules offer a comprehensive approach to neurological wellness.\n\nWhat Are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules?\n\nThese capsules combine six powerful ingredients known for their nerve-protective and restorative properties:\n\nBenfotiamine\nMecobalamin (Methylcobalamin)\nPyridoxine Hydrochloride (Vitamin B6)\nFolic Acid (Vitamin B9)\nInositol\nAlpha Lipoic Acid\n\nTogether, these ingredients help support healthy nerve function, improve metabolic processes, and protect nerve tissues from damage caused by oxidative stress and elevated blood sugar levels.\n\nHow Do Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules Work?\n\nThe effectiveness of this formulation lies in its multi-dimensional mechanism of action.\n\nBenfotiamine\n\nBenfotiamine is a fat-soluble derivative of Vitamin B1 that offers superior absorption.\n\nIt helps:\n\nProtect nerves from glucose-induced damage\nImprove nerve conductivity\nReduce diabetic complications\nSupport healthy metabolism\nMecobalamin\n\nMecobalamin is an active form of Vitamin B12 that plays a critical role in nerve regeneration.\n\nBenefits include:\n\nRepairing damaged nerve cells\nSupporting myelin sheath formation\nEnhancing nerve signal transmission\nReducing neuropathic symptoms\nPyridoxine Hydrochloride\n\nVitamin B6 supports neurological and metabolic functions.\n\nIt helps:\n\nMaintain healthy nerve cells\nImprove neurotransmitter production\nSupport brain and nervous system function\nFolic Acid\n\nFolic Acid contributes to:\n\nDNA synthesis\nRed blood cell production\nNerve cell development\nHomocysteine reduction\nInositol\n\nInositol assists in:\n\nNerve signaling pathways\nCellular communication\nMetabolic regulation\nNeurological function support\nAlpha Lipoic Acid\n\nAlpha Lipoic Acid is a potent antioxidant.\n\nIt helps:\n\nNeutralize free radicals\nReduce oxidative stress\nImprove nerve blood flow\nRelieve symptoms of diabetic neuropathy\nKey Benefits of Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nThis unique formulation offers multiple health benefits.\n\nSupports Nerve Regeneration\n\nThe combination promotes repair and regeneration of damaged nerve tissues.\n\nHelps Manage Diabetic Neuropathy\n\nMany diabetic patients experience:\n\nTingling sensations\nBurning feet\nNumbness\nSharp nerve pain\n\nThese capsules help manage such symptoms effectively.\n\nReduces Oxidative Stress\n\nAlpha Lipoic Acid protects nerves from oxidative damage caused by free radicals.\n\nImproves Nerve Conduction\n\nMecobalamin and Benfotiamine help restore healthy nerve signaling pathways.\n\nEnhances Energy Metabolism\n\nB-complex vitamins improve cellular energy production and metabolic efficiency.\n\nSupports Brain and Cognitive Function\n\nEssential vitamins support neurological health and mental performance.\n\nHelps Prevent Vitamin Deficiencies\n\nProvides important nutrients often deficient in diabetic and elderly patients.\n\nWhy Doctors Recommend Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nHealthcare professionals commonly prescribe this combination because it addresses the underlying nutritional and oxidative factors contributing to nerve damage.\n\nDoctors often recommend these capsules for:\n\nDiabetic neuropathy\nPeripheral neuropathy\nVitamin B12 deficiency\nNerve pain management\nNutritional supplementation\nNeurological disorders\nRecovery from nerve injuries\n\nThe synergistic action of these ingredients offers broader therapeutic benefits than single-nutrient supplements.\n\nIndications\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are commonly indicated for:\n\nDiabetic Neuropathy\n\nHelps reduce symptoms associated with diabetes-related nerve damage.\n\nPeripheral Neuropathy\n\nSupports nerve health in patients experiencing nerve dysfunction.\n\nVitamin B Complex Deficiencies\n\nProvides nutritional support for individuals with inadequate vitamin intake.\n\nNerve Pain\n\nHelps manage neuropathic discomfort and sensory disturbances.\n\nMetabolic Neuropathy\n\nSupports patients affected by metabolic conditions impacting nerve function.\n\nNeurological Support\n\nUseful in maintaining healthy nervous system function.\n\nWho Should Consider These Capsules?\n\nThese capsules may benefit:\n\nIndividuals with diabetes\nPatients experiencing numbness or tingling\nElderly individuals with nerve weakness\nPeople recovering from neurological disorders\nIndividuals with vitamin B deficiencies\nPatients with chronic nerve pain\n\nA healthcare professional can determine if this supplement is appropriate based on individual medical needs.\n\nDosage and Administration\n\nAlways take Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules as directed by your healthcare provider.\n\nGeneral Guidelines\nUsually taken once daily or as prescribed\nSwallow the capsule whole with water\nPreferably taken after meals\nFollow the recommended dosage schedule\n\nDo not exceed the prescribed dose without medical advice.\n\nPossible Side Effects\n\nMost patients tolerate these capsules well. However, some individuals may experience mild side effects.\n\nCommon side effects may include:\n\nNausea\nStomach discomfort\nMild headache\nDizziness\nBloating\nSkin rash\nAllergic reactions\n\nThese side effects are generally temporary and manageable.\n\nPrecautions and Warnings\n\nBefore taking these capsules, consider the following precautions:\n\nConsult Your Doctor If You Have:\nKidney disease\nLiver disorders\nSevere diabetes complications\nAllergies to any ingredient\nPregnancy and Breastfeeding\n\nUse only under medical supervision during pregnancy and lactation.\n\nDrug Interactions\n\nInform your doctor about:\n\nAntidiabetic medications\nAnticonvulsants\nVitamin supplements\nPrescription medications\nRegular Monitoring\n\nPatients with diabetes should continue monitoring blood glucose levels as advised.\n\nWhy Choose This Advanced Nerve Health Formula?\n\nThe combination of Benfotiamine, Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol, and Alpha Lipoic Acid provides comprehensive support through multiple mechanisms.\n\nKey advantages include:\n\nMulti-nutrient nerve support\nEnhanced antioxidant protection\nImproved nerve regeneration\nBetter diabetic neuropathy management\nConvenient single-capsule formulation\nLong-term neurological health benefits\n\nThis makes it an excellent choice for individuals seeking a scientifically formulated nerve support supplement.\n\nConclusion\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules represent a comprehensive solution for supporting nerve health, managing diabetic neuropathy, and addressing nutritional deficiencies that affect neurological function. The synergistic combination of neurotropic vitamins and powerful antioxidants helps repair damaged nerves, improve nerve conduction, reduce oxidative stress, and promote overall neurological wellness.\n\nFor individuals experiencing nerve pain, numbness, tingling sensations, or diabetic neuropathy symptoms, these capsules offer an effective and clinically trusted option. When used under medical supervision, they can play a valuable role in maintaining healthy nerve function and improving quality of life.\n\nFrequently Asked Questions (FAQs)\n1. What are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules used for?\n\nThey are primarily used to support nerve health, manage diabetic neuropathy, and treat vitamin B deficiencies.\n\n2. Can these capsules help with diabetic neuropathy?\n\nYes. The combination is commonly prescribed to help reduce symptoms such as tingling, numbness, burning sensations, and nerve pain associated with diabetic neuropathy.\n\n3. How long does it take to see results?\n\nResults vary depending on the severity of nerve damage and individual health conditions. Consistent use as prescribed is important.\n\n4. Are these capsules safe for long-term use?\n\nWhen taken under medical supervision, they are generally considered safe for long-term nutritional and neurological support.\n\n5. Can non-diabetic patients take these capsules?\n\nYes. They may also be prescribed for vitamin deficiencies, peripheral neuropathy, and other nerve-related conditions.\n\n6. Do these capsules require a prescription?\n\nAvailability may vary by region, but it is always recommended to use them under the guidance of a healthcare professional.", "price": 390.0, "discountamount": 117.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2435, "imageuri": "https://productimages.withfloats.com/actual/6a1ec0fefe6140386d7a9074.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1ec0fefe6140386d7a9074.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-02T11:39:39.761Z", "updatedon": "2026-06-04T07:08:32.501Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benfotiamine-mecobalamin-pyridoxine-hydrochloride-folic-acid-inositol-alpha-lipoic-acid-capsules/2435", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NUTRIDIAB PN", "category": "NEUROLOGY RANGE", "tags": [ "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "Methylcobalamin alpha lipoic acid Pyridoxine Folic Acid Benfotiamine", "Benfotiamine Mecobalamin Pyridoxine Hydrochloride Folic Acid Inositol Alpha Lipoic Acid Capsules", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Diabetic Neuropathy Treatment Capsules", "Benfotiamine and Mecobalamin Capsules for Nerve Pain", "Alpha Lipoic Acid Capsules for Diabetic Neuropathy", "Vitamin B Complex and Alpha Lipoic Acid Capsules", "Benfotiamine Mecobalamin Capsules Product Image", "Best Capsules for Diabetic Nerve Damage", "Nerve Regeneration and Nerve Support Capsules", "Vitamin B12 and Alpha Lipoic Acid Capsules", "Nerve Strengthening Capsules with Benfotiamine", "Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules for Neuropathy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a1d7da71f450faabc228b8d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "description": "Managing Type 2 diabetes requires a comprehensive approach that helps control blood sugar levels while reducing the risk of long-term complications. The Gliclazide and Dapagliflozin combination is a modern and effective treatment option prescribed by healthcare professionals to improve glycemic control in adults with Type 2 diabetes mellitus. This combination works through two different mechanisms to help maintain healthy blood glucose levels, making it a preferred choice for patients who need better diabetes management.\n\nIf you are looking for a reliable diabetes treatment option, understanding the benefits, uses, and working mechanism of the Gliclazide and Dapagliflozin combination can help you make an informed decision in consultation with your healthcare provider.\n\nWhat is Gliclazide and Dapagliflozin Combination?\n\nThe Gliclazide and Dapagliflozin combination is an oral anti-diabetic medication used to control blood sugar levels in patients with Type 2 diabetes. It combines two powerful medicines:\n\nGliclazide – A sulfonylurea that stimulates the pancreas to release more insulin.\nDapagliflozin – An SGLT2 inhibitor that helps the kidneys remove excess glucose through urine.\n\nTogether, these medicines provide dual-action blood sugar control and help patients achieve better glycemic targets when diet, exercise, and single-drug therapy are insufficient.\n\nHow Does Gliclazide and Dapagliflozin Combination Work?\n\nThe effectiveness of this combination lies in its complementary mechanisms of action.\n\nGliclazide Action\n\nGliclazide works by stimulating the beta cells in the pancreas to produce and release more insulin. Increased insulin production helps transport glucose from the bloodstream into body cells, where it is used for energy.\n\nDapagliflozin Action\n\nDapagliflozin blocks the Sodium-Glucose Co-Transporter 2 (SGLT2) protein in the kidneys. This action reduces glucose reabsorption and allows excess sugar to be eliminated through urine, lowering blood glucose levels.\n\nCombined Benefits\n\nWhen used together, Gliclazide and Dapagliflozin help:\n\nReduce fasting blood sugar levels\nLower post-meal glucose spikes\nImprove HbA1c levels\nSupport long-term diabetes management\nProvide complementary glucose-lowering effects\nUses of Gliclazide and Dapagliflozin Combination\n\nHealthcare professionals commonly prescribe this combination for:\n\nType 2 Diabetes Mellitus\n\nThe primary use of the Gliclazide and Dapagliflozin combination is the treatment of Type 2 diabetes in adults whose blood sugar levels are not adequately controlled by lifestyle modifications alone.\n\nImproved Glycemic Control\n\nThis medication helps patients achieve better glycemic control and maintain stable blood glucose levels throughout the day.\n\nCombination Diabetes Therapy\n\nIt is often recommended when monotherapy with a single anti-diabetic medication fails to provide satisfactory results.\n\nLong-Term Diabetes Management\n\nThe combination can be used as part of a comprehensive diabetes management plan that includes healthy eating, exercise, and regular monitoring.\n\nBenefits of Gliclazide and Dapagliflozin Combination\n1. Dual Mechanism of Action\n\nThe combination attacks high blood sugar from two different angles, resulting in more effective glucose control.\n\n2. Better HbA1c Reduction\n\nPatients often experience significant reductions in HbA1c levels compared to treatment with a single medication.\n\n3. Effective Fasting and Postprandial Control\n\nThe medicine helps manage both fasting blood glucose and post-meal sugar spikes.\n\n4. Convenient Treatment Option\n\nCombining two medications into one treatment regimen can improve patient compliance and simplify diabetes management.\n\n5. Supports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin may contribute to modest weight reduction due to the elimination of excess glucose through urine.\n\n6. Cardiovascular Benefits\n\nDapagliflozin has been associated with cardiovascular benefits in certain patients, making it an attractive option for individuals with Type 2 diabetes and cardiovascular risk factors.\n\n7. Reduced Risk of Diabetes Complications\n\nMaintaining better blood sugar control may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.\n\nWhy Choose Gliclazide and Dapagliflozin Combination?\n\nThe growing popularity of this combination therapy stems from its ability to provide comprehensive blood sugar management. Physicians often recommend it because:\n\nIt targets multiple pathways involved in glucose regulation.\nIt provides strong glycemic control.\nIt helps reduce HbA1c effectively.\nIt offers potential weight-related benefits.\nIt supports long-term diabetes care goals.\n\nPatients seeking improved diabetes control often find this combination beneficial when prescribed and monitored by a healthcare professional.\n\nRecommended Dosage\n\nThe dosage of the Gliclazide and Dapagliflozin combination should always be determined by a healthcare provider based on:\n\nAge\nBlood glucose levels\nHbA1c values\nMedical history\nKidney function\nResponse to treatment\n\nPatients should take the medication exactly as prescribed and should not alter the dosage without medical advice.\n\nPrecautions Before Using Gliclazide and Dapagliflozin Combination\n\nBefore starting treatment, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart conditions\nFrequent urinary tract infections\nHistory of diabetic ketoacidosis\nSevere dehydration\nLow blood pressure\n\nPregnant and breastfeeding women should consult their healthcare provider before using this medication.\n\nPossible Side Effects\n\nLike all medications, the Gliclazide and Dapagliflozin combination may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased urination\nThirst\nHeadache\nDizziness\nFatigue\nMild gastrointestinal discomfort\nHypoglycemia Symptoms\n\nSince Gliclazide stimulates insulin release, some patients may experience low blood sugar, especially when meals are skipped.\n\nSymptoms may include:\n\nSweating\nHunger\nTrembling\nWeakness\nConfusion\nRapid heartbeat\nUrinary and Genital Infections\n\nDapagliflozin increases glucose excretion through urine, which may increase the likelihood of:\n\nUrinary tract infections\nGenital fungal infections\n\nPrompt medical attention should be sought if symptoms occur.\n\nLifestyle Tips for Better Diabetes Control\n\nFor optimal results with the Gliclazide and Dapagliflozin combination, patients should follow a healthy lifestyle.\n\nMaintain a Balanced Diet\n\nFocus on:\n\nWhole grains\nVegetables\nFruits in moderation\nLean proteins\nHealthy fats\n\nAvoid excessive consumption of sugary foods and beverages.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and supports blood sugar control. Aim for at least 150 minutes of moderate exercise per week, as advised by your healthcare provider.\n\nMonitor Blood Sugar\n\nRegular blood glucose monitoring helps track treatment effectiveness and allows timely adjustments when necessary.\n\nStay Hydrated\n\nBecause Dapagliflozin increases urinary glucose excretion, adequate hydration is important to prevent dehydration.\n\nAttend Regular Checkups\n\nRoutine medical visits help monitor:\n\nHbA1c levels\nKidney function\nBlood pressure\nOverall diabetes control\nWho Can Benefit from Gliclazide and Dapagliflozin Combination?\n\nThis combination may be suitable for:\n\nAdults with Type 2 diabetes\nPatients requiring stronger glucose control\nIndividuals not achieving targets with single-drug therapy\nPatients seeking a dual-action diabetes treatment approach\nIndividuals requiring comprehensive glycemic management under medical supervision\nConclusion\n\nThe Gliclazide and Dapagliflozin combination is an advanced and effective treatment option for adults with Type 2 diabetes mellitus. By combining the insulin-stimulating action of Gliclazide with the glucose-eliminating benefits of Dapagliflozin, this therapy provides comprehensive blood sugar control and supports long-term diabetes management goals.\n\nWith benefits such as improved HbA1c reduction, fasting and post-meal glucose control, convenient therapy, and potential cardiovascular advantages, this combination has become an important choice in modern diabetes care. When used alongside a healthy diet, regular exercise, and proper medical supervision, the Gliclazide and Dapagliflozin combination can help patients achieve better glycemic control and improve their overall quality of life.", "price": 470.0, "discountamount": 141.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2433, "imageuri": "https://productimages.withfloats.com/actual/6a1d7da92f2aa2676dd01915.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1d7da92f2aa2676dd01915.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-01T12:40:07.196Z", "updatedon": "2026-06-04T07:19:16.331Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclazide-sr-60mg-and-dapagliflozin-10mg-tablet/2433", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclaglaze DAPA 60-10", "category": "DIABETIC RANGE", "tags": [ "gliclazide and dapagliflozin combination", "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "gliclazide and dapagliflozin", "gliclazide and dapagliflozin together", "gliclazide dapagliflozin", "Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets", "Buy Gliclazide SR 60 mg Dapagliflozin 10 mg Tablets Online", "Type 2 Diabetes Treatment Tablets", "Gliclazide and Dapagliflozin Diabetes Medicine", "Gliclazide SR 60 mg Dapagliflozin 10 mg Product Image", "Best Tablets for Type 2 Diabetes Management", "Blood Sugar Control Tablets Gliclazide Dapagliflozin", "Gliclazide SR and Dapagliflozin Combination Tablets", "Diabetes Management Medicine Gliclazide Dapagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69f1f2ab0401258bafb82cd7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets", "description": "Managing type 2 diabetes effectively often requires a combination of medicines that work together to control blood sugar levels. DAPAVILDA MET 10/100/500 is a powerful triple-combination tablet formulated with Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg Tablets. This advanced formulation is designed to help adults with type 2 diabetes maintain better glucose control, improve insulin response, and support overall metabolic health.\n\nIf you are looking for a trusted diabetes management tablet, DAPAVILDA MET 10/100/500 offers a convenient once-daily option under medical supervision.\n\nWhat is DAPAVILDA MET 10/100/500?\n\nDAPAVILDA MET 10/100/500 is a combination medicine used to treat Type 2 Diabetes Mellitus when diet, exercise, or single-drug therapy is not enough to control blood sugar. It contains three clinically proven ingredients:\n\nDapagliflozin 10 mg – Helps remove excess sugar through urine.\nVildagliptin SR 100 mg – Enhances insulin secretion and reduces glucagon release.\nMetformin SR 500 mg – Reduces glucose production in the liver and improves insulin sensitivity.\n\nThis triple-action therapy helps patients achieve better glycemic control and reduces diabetes-related complications.\n\nHow DAPAVILDA MET 10/100/500 Works\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by blocking glucose reabsorption in the kidneys, allowing excess sugar to pass out through urine. This helps lower blood sugar naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels. These hormones stimulate insulin release after meals and reduce unnecessary glucose production.\n\n3. Metformin SR 500 mg\n\nMetformin is one of the most trusted diabetes medicines. It decreases glucose production in the liver and improves the body's response to insulin.\n\nTogether, these ingredients provide comprehensive blood sugar management throughout the day.\n\nUses of DAPAVILDA MET 10/100/500\n\nDAPAVILDA MET 10/100/500 Tablets are primarily used for:\n\n✔ Type 2 Diabetes Mellitus\n\nHelps manage high blood sugar levels in adults with type 2 diabetes.\n\n✔ Poorly Controlled Diabetes\n\nUseful when blood sugar remains high despite lifestyle changes or single/dual therapy.\n\n✔ Reduction of HbA1c Levels\n\nSupports long-term sugar control and helps reduce HbA1c.\n\n✔ Weight Management Support\n\nDapagliflozin may assist in mild weight reduction in some diabetic patients.\n\n✔ Improved Metabolic Health\n\nHelps improve insulin sensitivity and glucose utilization.\n\nKey Benefits of DAPAVILDA MET 10/100/500\n1. Triple Combination Formula\n\nThree effective medicines in one tablet for better sugar control.\n\n2. Better Fasting and Post-Meal Sugar Control\n\nHelps control both fasting blood sugar and postprandial spikes.\n\n3. Convenient Once Daily Dosage\n\nSustained release formula supports long-lasting action.\n\n4. Supports Weight Balance\n\nMay help reduce calorie overload through urinary glucose excretion.\n\n5. Helps Lower Risk of Diabetes Complications\n\nGood sugar control may reduce risk of kidney, nerve, eye, and heart problems.\n\n6. Improves Insulin Function\n\nSupports natural insulin release when needed.\n\nWho Can Use DAPAVILDA MET 10/100/500?\n\nThis medicine may be prescribed for:\n\nAdults with type 2 diabetes\nPatients needing triple-drug therapy\nOverweight diabetic individuals\nPatients with uncontrolled HbA1c\nIndividuals requiring convenient once-daily medication\n\nAlways use only after doctor consultation.\n\nRecommended Dosage\n\nThe dosage of DAPAVILDA MET 10/100/500 should be decided by a physician depending on:\n\nBlood sugar levels\nHbA1c results\nKidney function\nExisting medications\nOverall health condition\nGeneral Advice:\nTake with food to reduce stomach upset.\nSwallow whole with water.\nDo not crush or chew SR tablet.\nTake at the same time daily.\nSide Effects of DAPAVILDA MET 10/100/500\n\nLike all medicines, some users may experience mild side effects.\n\nCommon Side Effects\nNausea\nStomach discomfort\nFrequent urination\nHeadache\nLoose stools\nDizziness\nLow appetite\nLess Common Side Effects\nUrinary tract infection\nGenital fungal infection\nDehydration\nWeakness\nSerious Side Effects (Need Immediate Medical Help)\nSevere low sugar (if used with insulin/sulfonylureas)\nLactic acidosis (rare)\nAllergic reaction\nSevere dehydration\nKidney problems\n\nIf unusual symptoms appear, contact a doctor immediately.\n\nPrecautions and Warnings\n\nBefore using DAPAVILDA MET 10/100/500, inform your doctor if you have:\n\nKidney disease\nLiver disease\nHeart problems\nFrequent urinary infections\nHistory of pancreatitis\nAlcohol dependency\nPregnancy or breastfeeding\nImportant:\n\nStay hydrated while taking dapagliflozin-containing medicines.\n\nLifestyle Tips for Better Results\n\nMedicine works best with healthy habits:\n\n✔ Follow a Diabetic Diet\n\nReduce sugar, refined carbs, and oily foods.\n\n✔ Exercise Daily\n\nAt least 30 minutes walking or physical activity.\n\n✔ Monitor Blood Sugar\n\nCheck regularly as advised.\n\n✔ Stay Hydrated\n\nEspecially important with dapagliflozin.\n\n✔ Take Medicine Regularly\n\nDo not skip doses.\n\nWhy Choose DAPAVILDA MET 10/100/500?\n\nPatients and doctors prefer DAPAVILDA MET 10/100/500 because:\n\nTrusted triple therapy\nEffective glucose lowering\nSustained release convenience\nBetter compliance with one tablet\nSuitable for long-term diabetes management under supervision\nStorage Instructions\nStore in a cool, dry place\nKeep away from sunlight\nKeep out of reach of children\nStore below recommended temperature\nConclusion\n\nDAPAVILDA MET 10/100/500 containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg and Metformin SR 500 mg Tablets is a highly effective triple-combination treatment for adults with type 2 diabetes. It helps lower blood sugar, improve insulin response, support weight control, and reduce long-term diabetes risks.", "price": 325.0, "discountamount": 98.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2393, "imageuri": "https://productimages.withfloats.com/actual/69f1f2adf974f5424d3a55fa.png", "tileimageuri": "https://productimages.withfloats.com/tile/69f1f2adf974f5424d3a55fa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-29T11:59:39.204Z", "updatedon": "2026-04-29T11:59:39.204Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-vildagliptin-sr-100-mg-and-metformin-sr-500-mg-tablets/2393", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPAVILDA MET 10/100/500", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d6115048622857aafcb373", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin 50 mg + dapagliflozin 5 mg", "description": "Managing type 2 diabetes effectively requires a balanced approach that includes medication, diet, and lifestyle changes. ST-Gliptin Dapa, a powerful dual-combination therapy containing Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, is designed to provide effective glycemic control for adults suffering from type 2 diabetes mellitus.\n\nThis innovative formulation works through two complementary mechanisms to help regulate blood sugar levels, reduce glucose reabsorption, and improve insulin response, making it a reliable choice for patients who need combination therapy.\n\nHow ST-Gliptin Dapa Works\n\nST-Gliptin Dapa combines two well-established antidiabetic agents that target different pathways in glucose metabolism:\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood sugar levels and also supports mild weight loss.\nSitagliptin phosphate is a DPP-4 inhibitor that increases incretin hormone levels. These hormones help stimulate insulin release after meals and reduce glucagon secretion, leading to better postprandial glucose control.\n\nTogether, these two medications provide comprehensive blood sugar control throughout the day, especially in patients who are not achieving adequate results with a single drug.\n\nUses of ST-Gliptin Dapa\n\nST-Gliptin Dapa is prescribed for the following:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate control on monotherapy\nReducing fasting and post-meal blood glucose levels\nImproving insulin secretion and sensitivity\nSupporting overall metabolic balance\n\nIt is usually recommended along with a proper diet and regular physical activity to achieve optimal results.\n\nKey Benefits of ST-Gliptin Dapa\n1. Dual Mechanism for Better Control\n\nThis combination works on both kidney and hormonal pathways, ensuring effective and sustained glucose reduction.\n\n2. Improved Glycemic Stability\n\nHelps reduce both fasting and postprandial blood sugar spikes, offering balanced control throughout the day.\n\n3. Weight Management Support\n\nDapagliflozin promotes glucose excretion, which can lead to modest weight loss, beneficial for overweight diabetic patients.\n\n4. Low Risk of Hypoglycemia\n\nCompared to insulin or sulfonylureas, this combination has a lower risk of causing hypoglycemia, making it safer for long-term use.\n\n5. Cardiovascular and Renal Benefits\n\nSGLT2 inhibitors like dapagliflozin are known to provide additional benefits for heart and kidney health when used under medical supervision.\n\n6. Enhanced Patient Compliance\n\nA fixed-dose combination reduces pill burden, making it easier for patients to follow their treatment plan consistently.\n\nDosage and Administration\nTake ST-Gliptin Dapa as prescribed by your healthcare provider\nTypically taken once daily, with or without food\nSwallow the tablet whole with water\nDo not skip doses or double up if a dose is missed\n\nAlways follow your doctor’s instructions for dosage adjustments based on your condition.\n\nSide Effects of ST-Gliptin Dapa\n\nLike all medications, ST-Gliptin Dapa may cause some side effects. Most are mild and manageable.\n\nCommon Side Effects\nFrequent urination\nThirst or dehydration\nHeadache\nNasopharyngitis (cold-like symptoms)\nMild gastrointestinal discomfort\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital fungal infections\nPancreatitis (associated with DPP-4 inhibitors)\nKidney function changes\nSevere allergic reactions\n\nIf you experience any unusual or severe symptoms, seek medical attention immediately.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney impairment\nUse cautiously in elderly patients\nMaintain proper hydration to avoid dehydration\nInform your doctor about any existing liver, kidney, or heart conditions\nAvoid excessive alcohol consumption\n\nPregnant and breastfeeding women should consult a doctor before using this medication.\n\nWho Should Use ST-Gliptin Dapa?\n\nThis medication is suitable for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients needing dual therapy for better control\nIndividuals who are overweight or have insulin resistance\nPatients who are not achieving targets with a single medication\nStorage Instructions\nStore in a cool and dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nST-Gliptin Dapa is a modern and effective dual-combination therapy that offers a comprehensive solution for managing type 2 diabetes. With the combined action of Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, it targets multiple pathways involved in glucose regulation, helping patients achieve better glycemic control.", "price": 290.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2370, "imageuri": "https://productimages.withfloats.com/actual/69d61153b9380b73ede65348.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/69d61153b9380b73ede65348.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-08T08:26:56.108Z", "updatedon": "2026-05-04T10:05:22.561Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-dapagliflozin-5-mg/2370", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST- GLIPTIN DAPA 50/5", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin sitagliptin phosphate tablets", "dapagliflozin sitagliptin phosphate", "Sitagliptin 50 Mg + Dapagliflozin 5 Mg", "dapagliflozin 5 mg sitagliptin 50 mg uses", "Sitagliptin 50 Mg + Dapagliflozin 5 Mg side effects", "dapagliflozin 5 mg sitagliptin 50 mg price in india", "buy sitagliptin 50 mg dapagliflozin 5 mg tablets", "sitagliptin dapagliflozin tablets wholesale price", "sitagliptin 50 mg + dapagliflozin 5 mg tablets", "dapagliflozin sitagliptin tablets bulk order" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698d91909e3c03f732124005", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Remogliflozin Etabonate Tablets 100 mg", "description": "REMOFLOZIN 100 is an advanced oral antidiabetic medication containing Remogliflozin Etabonate 100 mg as its active pharmaceutical ingredient. This innovative formulation represents a significant breakthrough in the management of Type 2 Diabetes Mellitus, offering patients a novel mechanism of action that works independently of insulin secretion or insulin sensitivity. REMOFLOZIN 100 belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitors class of medications, which has revolutionized diabetes management by targeting glucose reabsorption in the kidneys rather than affecting pancreatic function or peripheral glucose utilization.\nDeveloped through rigorous scientific research and clinical trials, REMOFLOZIN 100 provides diabetic patients with an effective therapeutic option that not only helps control blood sugar levels but also offers additional cardiovascular and metabolic benefits. Each tablet is precisely formulated to deliver consistent and reliable glycemic control, making it an essential component in the comprehensive management of Type 2 Diabetes.\nHow REMOFLOZIN 100 Works\nThe mechanism of action of REMOFLOZIN 100 is both unique and highly effective. Under normal physiological conditions, the kidneys filter glucose from the blood, but the SGLT2 proteins in the proximal renal tubules reabsorb approximately 90% of this filtered glucose back into the bloodstream. In diabetic patients, this reabsorption continues even when blood glucose levels are elevated, perpetuating hyperglycemia.\nRemogliflozin Etabonate works by selectively inhibiting the SGLT2 proteins in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion. This insulin-independent mechanism allows the body to eliminate excess glucose naturally through urine, leading to sustained reductions in blood glucose levels. The medication typically begins working within hours of administration, with maximum therapeutic effects observed within several weeks of consistent use.\nPrimary Uses and Indications\nREMOFLOZIN 100 is primarily indicated for:\nManagement of Type 2 Diabetes Mellitus: As monotherapy in patients who cannot tolerate metformin or for whom metformin is contraindicated, and as combination therapy with other antidiabetic agents including metformin, sulfonylureas, or insulin when existing treatment regimens fail to achieve adequate glycemic control.\nGlycemic Control Optimization: For patients requiring additional blood sugar management beyond diet and exercise modifications, REMOFLOZIN 100 helps reduce both fasting plasma glucose and postprandial glucose levels.\nAdjunct to Lifestyle Modifications: The medication works synergistically with dietary modifications and regular physical activity to achieve comprehensive diabetes management and reduce the risk of long-term diabetic complications.\nKey Benefits of REMOFLOZIN 100\nSuperior Glycemic Control\nREMOFLOZIN 100 demonstrates significant efficacy in reducing HbA1c levels, typically achieving reductions of 0.5% to 1.0% when used as monotherapy and even greater reductions when combined with other antidiabetic medications. This improvement in long-term glucose control translates to reduced risk of microvascular complications, including diabetic retinopathy, nephropathy, and neuropathy.\nWeight Management Support\nUnlike many traditional antidiabetic medications that may cause weight gain, REMOFLOZIN 100 is associated with modest weight loss, typically ranging from 2 to 4 kilograms over several months of treatment. This weight reduction occurs due to caloric loss through urinary glucose excretion and may provide additional metabolic benefits for overweight or obese diabetic patients.\nCardiovascular Benefits\nEmerging research on SGLT2 inhibitors suggests potential cardiovascular protective effects, including modest reductions in blood pressure and improvements in various cardiovascular risk markers. These benefits may be particularly valuable for diabetic patients who are at increased risk of cardiovascular disease.\nLow Risk of Hypoglycemia\nBecause REMOFLOZIN 100 works independently of insulin secretion, it carries a minimal risk of hypoglycemia when used as monotherapy. This safety profile makes it particularly suitable for elderly patients or those at higher risk of dangerous low blood sugar episodes.\nRenal Function Considerations\nThe medication may offer nephroprotective benefits by reducing intraglomerular pressure and proteinuria in diabetic patients, potentially slowing the progression of diabetic kidney disease.\nConvenient Once-Daily Dosing\nREMOFLOZIN 100's pharmacokinetic profile allows for convenient once-daily administration, improving patient compliance and treatment adherence.\nPotential Side Effects and Safety Considerations\nWhile REMOFLOZIN 100 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects\n\nGenital Mycotic Infections: Increased glucose in urine may promote fungal infections, particularly in women\nUrinary Tract Infections: More frequent urination and glucose in urine may increase UTI risk\nIncreased Urination: Polyuria is expected due to the medication's mechanism of action\nThirst: Patients may experience increased thirst due to fluid loss\nDizziness: Particularly when standing up quickly, due to mild blood pressure reductions\n\nSerious but Rare Side Effects\n\nDiabetic Ketoacidosis: Although rare, euglycemic DKA has been reported with SGLT2 inhibitors\nAcute Kidney Injury: Dehydration may affect kidney function in susceptible individuals\nLower Limb Amputation: Some SGLT2 inhibitors have shown increased risk in specific populations\nHypotension: Particularly in patients on diuretics or with compromised cardiovascular function\n\nContraindications and Precautions\nREMOFLOZIN 100 should not be used in patients with type 1 diabetes, severe renal impairment, diabetic ketoacidosis, or those with known hypersensitivity to the drug. Pregnant and breastfeeding women should avoid this medication. Patients should maintain adequate hydration and practice proper genital hygiene to minimize infection risks.\nDosage and Administration Guidelines\nThe standard recommended dose is one REMOFLOZIN 100 tablet taken orally once daily, preferably at the same time each day. The medication can be taken with or without food. Patients should not double doses if they miss a scheduled dose but should take the next dose at the regular time. Dosage adjustments may be necessary based on individual response, renal function, and concomitant medications. Regular monitoring of blood glucose levels, kidney function, and HbA1c is essential for optimal treatment management.\nConclusion\nREMOFLOZIN 100 represents a valuable therapeutic advancement in type 2 diabetes management, offering patients an innovative approach to glycemic control through its unique renal mechanism of action. The medication's ability to reduce blood sugar levels while providing additional benefits such as weight loss, cardiovascular protection, and low hypoglycemia risk makes it an attractive option for many diabetic patients.", "price": 335.0, "discountamount": 101.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2301, "imageuri": "https://productimages.withfloats.com/actual/698d9191cd6033ecce84b352.png", "tileimageuri": "https://productimages.withfloats.com/tile/698d9191cd6033ecce84b352.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-12T08:38:40.037Z", "updatedon": "2026-03-13T11:02:30.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//remogliflozin-etabonate-tablets-100-mg/2301", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REMOFLOZIN 100", "category": "DIABETIC RANGE", "tags": [ "Remogliflozin Etabonate 100mg tablets for type 2 diabetes", "Remogliflozin 100mg oral diabetes medication", "Remogliflozin Etabonate tablets 100mg prescription", "Remogliflozin 100 mg SGLT2 inhibitor tablets", "Remogliflozin Etabonate 100mg diabetes control tablets", "Buy Remogliflozin 100mg tablets online", "Remogliflozin Etabonate 100mg pack price", "Remogliflozin 100mg tablets for blood sugar management" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2026-03-13T10:20:54.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10mg-and-pioglitazone-15mg-tablets/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " GLIDAPA PIO", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }